INCIDENCE OF COMORBIDITY OF VITAMIN D3 DEFICIENCY IN PATIENTS WITH DEPRESSIVE DISORDER AND CORRELATION OF THE DEFICIENCY WITH DEPRESSIVE SYMPTOMATOLOGY: A CROSS-SECTIONAL HOSPITAL-BASED STUDY
Main Article Content
Keywords
Depression; Vitamin D3 deficiency; Hamilton Depression Rating Scale; Comorbidity; Cross-sectional study
Abstract
Depressive disorder is a significant global public health issue with very high morbidity, mortality and socioeconomic cost. Recent studies anticipate the possibility of the relationship between the deficiency of Vitamin D3 and depressive disorders; nonetheless, the data on Indian clinical populations is insufficient.
Aim: To evaluate the comorbidity of Vitamin D3 deficiency in patients with depressive disorder and to assess the correlation between serum Vitamin D3 levels and severity of depressive symptomatology. Methods: This hospital-based cross-sectional study was conducted among 54 patients diagnosed with depressive disorder who attended the Psychiatry Outpatient Department of a tertiary care centre. The severity of depression was evaluated using the Hamilton Depression Rating Scale (HDRS), while serum Vitamin D3 levels were estimated and classified into appropriate categories. Descriptive statistical methods and correlation analysis were then used to explore the association between Vitamin D3 status and the severity of depressive symptoms.
Results: A high prevalence of suboptimal Vitamin D3 levels was observed, with Vitamin D insufficiency being the most common category. An inverse relationship was noted between serum Vitamin D3 levels and severity of depressive symptoms, with lower Vitamin D3 levels associated with greater depression severity.
Conclusion: Depression disorder is a disease with high levels of vitamin D3 deficiency and correlates with more severe depressive symptoms, which implies the possibility of using Vitamin D3 assessment in the clinical environment.
References
2. Belzeaux, R., Boyer, L., Féron, F., Leboyer, M., & Fond, G. (2015). Mood disorders are associated with a more severe hypovitaminosis D than schizophrenia. Psychiatry Research, 229(1–2), 613–
616. https://www.sciencedirect.com/science/article/pii/S0165178115002619
3. Bertone-Johnson, E. R. (2009). Vitamin D and the occurrence of depression: Causal association or circumstantial evidence? Nutrition Reviews, 67(8), 481–492.
https://academic.oup.com/nutritionreviews/article-abstract/67/8/481/1839131
4. Chan, R., Chan, D., Woo, J., Ohlsson, C., Mellström, D., Kwok, T., & Leung, P. (2011). Association between serum 25-hydroxyvitamin D and psychological health in older Chinese men in a cohort study. Journal of Affective Disorders, 130(1–2), 251–259. https://www.sciencedirect.com/science/article/pii/S0165032710006439
5. Depression, W. H. O. (2017). Other common mental disorders: Global health estimates. Geneva: World Health Organisation, 24(1).
6. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010). A meta-analysis of cytokines in major depression. Biological Psychiatry, 67(5), 446–457. https://www.sciencedirect.com/science/article/pii/S0006322309012293
7. Eyles, D. W., Burne, T. H., & McGrath, J. J. (2013). Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease.
Frontiers in Neuroendocrinology, 34(1), 47–64.
https://www.sciencedirect.com/science/article/pii/S0091302212000295
8. Garcion, E., Wion-Barbot, N., Montero-Menei, C. N., Berger, F., & Wion, D. (2002). New clues about vitamin D functions in the nervous system. Trends in Endocrinology & Metabolism, 13(3),
100–105. https://www.cell.com/trends/endocrinology-metabolism/abstract/S10432760(01)00547-1
9. Gupta, A. (2014). Vitamin D deficiency in India: Prevalence, causalities and interventions. Nutrients, 6(2), 729–775. https://www.mdpi.com/2072-6643/6/2/729
10. Harinarayan, C. V., Ramalakshmi, T., & Venkataprasad, U. (2004). High prevalence of low dietary calcium and low vitamin D status in healthy south Indians. Asia Pacific Journal of Clinical
Nutrition, 13(4). https://www.researchgate.net/profile/Dr-Prasad-
Uv/publication/260246234_High_prevalence_of_low_dietary_calcium_and_low_vitamin_D_stat us_in_healthy_South_Indians/links/00b7d5304c2e720d5e000000/High-prevalence-of-lowdietary-calcium-and-low-vitamin-D-status-in-healthy-South-Indians.pdf
11. Hoogendijk, W. J., Lips, P., Dik, M. G., Deeg, D. J., Beekman, A. T., & Penninx, B. W. (2008). Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Archives of General Psychiatry, 65(5), 508–512.
https://jamanetwork.com/journals/jamapsychiatry/article-abstract/482702
12. Jorde, R., Sneve, M., Figenschau, Y., Svartberg, J., & Waterloo, K. (2008). Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: Randomized double blind trial. Journal of Internal Medicine, 264(6), 599–609. https://doi.org/10.1111/j.13652796.2008.02008.x
13. Ju, S.-Y., Lee, Y.-J., & Jeong, S.-N. (2013). Serum 25-hydroxyvitamin D levels and the risk of depression: A systematic review and meta-analysis. The Journal of Nutrition, Health and Aging,
17(5), 447–455. https://www.sciencedirect.com/science/article/pii/S1279770723017840
14. Kesby, J. P., Cui, X., Burne, T. H., & Eyles, D. W. (2013). Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophrenia. Frontiers in Cellular
Neuroscience, 7, 111. https://www.frontiersin.org/journals/cellularneuroscience/articles/10.3389/fncel.2013.00111/full
15. Kessler, R. C., Akiskal, H. S., Ames, M., Birnbaum, H., Greenberg, P., .A, R. M., Jin, R., Merikangas, K. R., Simon, G. E., & Wang, P. S. (2006). Prevalence and Effects of Mood Disorders on Work Performance in a Nationally Representative Sample of U.S. Workers. American Journal of Psychiatry, 163(9), 1561–1568. https://doi.org/10.1176/ajp.2006.163.9.1561
16. Khoraminya, N., Tehrani-Doost, M., Jazayeri, S., Hosseini, A., & Djazayery, A. (2013). Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder.
Australian & New Zealand Journal of Psychiatry, 47(3), 271–275. https://doi.org/10.1177/0004867412465022
17. Lee, D. M., Tajar, A., O’Neill, T. W., O’Connor, D. B., Bartfai, G., Boonen, S., Bouillon, R.,
Casanueva, F. F., Finn, J. D., Forti, G., Giwercman, A., Han, T. S., Huhtaniemi, I. T., Kula, K., Lean, M. E., Punab, M., Silman, A. J., Vanderschueren, D., Wu, F. C., … the EMAS study group. (2011). Lower vitamin D levels are associated with depression among community-dwelling European men. Journal of Psychopharmacology, 25(10), 1320–1328. https://doi.org/10.1177/0269881110379287
18. May, H. T., Bair, T. L., Lappé, D. L., Anderson, J. L., Horne, B. D., Carlquist, J. F., & Muhlestein, J. B. (2010). Association of vitamin D levels with incident depression among a general cardiovascular population. American Heart Journal, 159(6), 1037–1043.
https://www.sciencedirect.com/science/article/pii/S0002870310002425
19. Milaneschi, Y., Shardell, M., Corsi, A. M., Vazzana, R., Bandinelli, S., Guralnik, J. M., & Ferrucci,
L. (2010). Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. The
Journal of Clinical Endocrinology & Metabolism, 95(7), 3225–3233.
https://academic.oup.com/jcem/article-abstract/95/7/3225/2596276
20. Patrick, R. P., & Ames, B. N. (2014). Vitamin D hormone regulates serotonin synthesis. Part 1:
Relevance for autism. The FASEB Journal, 28(6), 2398–2413. https://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fj.13-246546
21. Prüfer, K., Veenstra, T. D., Jirikowski, G. F., & Kumar, R. (1999). Distribution of 1, 25dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. Journal of
Chemical Neuroanatomy, 16(2), 135–145.
https://www.sciencedirect.com/science/article/pii/S0891061899000022
22. Shaffer, J. A., Edmondson, D., Wasson, L. T., Falzon, L., Homma, K., Ezeokoli, N., Li, P., &
Davidson, K. W. (2014). Vitamin D supplementation for depressive symptoms: A systematic review
and meta-analysis of randomized controlled trials. Psychosomatic Medicine, 76(3), 190–196. https://journals.lww.com/psychosomaticmedicine/fulltext/2014/04000/vitamin_d_supplementatio n_for_depressive_symptoms_.9.aspx
23. Song, C., & Wang, H. (2011). Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35(3), 760–768. https://www.sciencedirect.com/science/article/pii/S027858461000237X
24. Spedding, S. (2014). Vitamin D and depression: A systematic review and meta-analysis comparing studies with and without biological flaws. Nutrients, 6(4), 1501–1518. https://www.mdpi.com/2072-6643/6/4/1501
25. Stewart, R., & Hirani, V. (2010). Relationship between vitamin D levels and depressive symptoms in older residents from a national survey population. Psychosomatic Medicine, 72(7), 608–612. https://journals.lww.com/psychosomaticmedicine/FullText/2010/09000/Relationship_Between_Vi tamin_D_Levels_and.2.aspx
26. Vellekkatt, F., & Menon, V. (2019). Efficacy of vitamin D supplementation in major depression: A meta-analysis of randomized controlled trials. Journal of Postgraduate Medicine, 65(2), 74–80. https://journals.lww.com/jopm/fulltext/2019/65020/efficacy_of_vitamin_d_supplementation_in_ major.4.aspx
27. Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., & Johns, N. (2013). Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. The
Lancet, 382(9904), 1575–1586. https://www.thelancet.com/journals/lancet/article/PIIS01406736(13)61611-6/fulltext?var=greenface

